Phase 1/2 Dose Finding, Safety and Efficacy Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)

Project: Research project

Project Details

StatusActive
Effective start/end date3/4/198/31/50

Funding

  • Pharmacyclics LLC